Purpose:
Our aim was to evaluate the safety and effectiveness of the
IRIS® bandage (Nephrokit®) on post-puncture bleeding compared to
conventional manual compression.
Methods:
Sixty-four patients, hemodialyzed with an arteriovenous
fistula, were enrolled in a 3-week prospective study. Conventional
manual compression was used during the first week, the IRIS® bandage
during the second week and conventional manual compression again during
the third week. The outcomes analyzed were the persistence or absence of
bleeding 3 minutes post-puncture with IRIS® device compared to
conventional manual compression. The safety of the IRIS® bandage was
also evaluated.
Results:
Rates of persistent bleeding 3 minutes post-puncture at
arterial sites were 53±6% and 56±5%, respectively, during the first and
third weeks (conventional compression) versus 18±5% during the second
week (IRIS® bandage). Similarly, rates of persistent bleeding 3 minutes
post-puncture at venous sites were 45±6% and 45±6%, respectively, with
conventional compression versus 23±5% with the IRIS® bandage. The
difference between the IRIS® device and conventional compression
therefore proved highly statistically significant (p<0.05) for both
arterial and venous puncture sites. No particular adverse events were
observed with the IRIS® device.
Conclusions:
Post-puncture bleeding time at arteriovenous fistula sites
is significantly shortened by the IRIS® bandage in comparison with
conventional manual compression.
Read complete article here